Bicocca Open Archive

Logo unimib boa
GERUSSI, ALESSIO
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
NA - Nord America 4.555
EU - Europa 3.155
AS - Asia 1.496
SA - Sud America 123
AF - Africa 15
OC - Oceania 2
Totale 9.346
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 4.518
IT - Italia 953
SG - Singapore 709
DE - Germania 577
SE - Svezia 427
RU - Federazione Russa 373
IE - Irlanda 334
HK - Hong Kong 325
CN - Cina 226
GB - Regno Unito 180
BR - Brasile 103
ID - Indonesia 75
NL - Olanda 54
AT - Austria 43
IN - India 42
FI - Finlandia 40
FR - Francia 31
CA - Canada 26
UA - Ucraina 26
VN - Vietnam 24
BE - Belgio 20
MY - Malesia 20
DK - Danimarca 17
TR - Turchia 11
CZ - Repubblica Ceca 10
IL - Israele 10
ES - Italia 9
LT - Lituania 8
PL - Polonia 8
SK - Slovacchia (Repubblica Slovacca) 8
IR - Iran 7
AR - Argentina 6
CH - Svizzera 6
GR - Grecia 6
PK - Pakistan 6
PT - Portogallo 6
IQ - Iraq 5
MX - Messico 5
TW - Taiwan 5
EC - Ecuador 4
JP - Giappone 4
MM - Myanmar 4
RO - Romania 4
RS - Serbia 4
ZA - Sudafrica 4
BO - Bolivia 3
EG - Egitto 3
KR - Corea 3
NO - Norvegia 3
SC - Seychelles 3
AZ - Azerbaigian 2
GH - Ghana 2
HU - Ungheria 2
KZ - Kazakistan 2
LA - Repubblica Popolare Democratica del Laos 2
LU - Lussemburgo 2
PA - Panama 2
PE - Perù 2
PY - Paraguay 2
AE - Emirati Arabi Uniti 1
AU - Australia 1
BD - Bangladesh 1
CI - Costa d'Avorio 1
CL - Cile 1
CO - Colombia 1
CR - Costa Rica 1
DO - Repubblica Dominicana 1
EE - Estonia 1
GE - Georgia 1
GT - Guatemala 1
HR - Croazia 1
JM - Giamaica 1
JO - Giordania 1
KG - Kirghizistan 1
KH - Cambogia 1
LI - Liechtenstein 1
LK - Sri Lanka 1
MA - Marocco 1
MD - Moldavia 1
MN - Mongolia 1
MU - Mauritius 1
NZ - Nuova Zelanda 1
OM - Oman 1
PH - Filippine 1
PS - Palestinian Territory 1
QA - Qatar 1
TH - Thailandia 1
UY - Uruguay 1
UZ - Uzbekistan 1
Totale 9.346
Salva come PNG Salva come JPEG
Città #
Ann Arbor 1.272
Singapore 481
Frankfurt am Main 473
Fairfield 361
Milan 350
Dublin 318
Hong Kong 318
Chandler 292
Wilmington 265
Ashburn 207
Santa Clara 187
Woodbridge 166
New York 145
Seattle 133
Houston 129
Cambridge 118
Chicago 100
London 99
Princeton 98
Jakarta 72
Shanghai 72
Dearborn 66
Altamura 46
Lawrence 46
Rome 45
Boardman 33
Helsinki 32
Moscow 29
Los Angeles 26
San Diego 26
Vienna 25
Monza 23
Beijing 22
Florence 21
Nuremberg 21
Pune 20
Brussels 19
Jacksonville 19
Council Bluffs 17
Penang 16
Guangzhou 15
Munich 15
Toronto 14
Bari 13
Nanjing 13
Turin 13
São Paulo 12
Mumbai 11
Andover 10
Lissone 10
Bologna 9
Brno 9
Fremont 9
Naples 9
Padova 9
Seregno 9
Dong Ket 8
Lappeenranta 8
Amsterdam 7
Dongguan 7
Hangzhou 7
Modena 7
Bergamo 6
Bratislava 6
Central 6
Dallas 6
Jinan 6
Kocaeli 6
Paris 6
Rovereto 6
Somma Vesuviana 6
Udine 6
Belo Horizonte 5
Cagliari 5
Carate Brianza 5
Delmar 5
Desio 5
Genoa 5
Huizen 5
Lisbon 5
Marietta 5
Sacramento 5
Shenyang 5
Washington 5
Appiano Gentile 4
Athens 4
Atlanta 4
Brescia 4
Castiglione del Lago 4
Changsha 4
Hebei 4
Hefei 4
Kruševac 4
Meda 4
Norwalk 4
Quanzhou 4
Rimini 4
Romola 4
Treviglio 4
Vancouver 4
Totale 6.616
Salva come PNG Salva come JPEG
Nome #
Pretreatment prediction of response to ursodeoxycholic acid in primary biliary cholangitis: development and validation of the UDCA Response Score 435
Quality of life in patients with primary biliary cholangitis: a cross-geographical comparison 260
Better end points needed in primary sclerosing cholangitis trials 227
Novel biomarkers for primary biliary cholangitis to improve diagnosis and understand underlying regulatory mechanisms 213
A second update on mapping the human genetic architecture of COVID-19 210
FRI-008-Incidence, prevalence and mortality of primary sclerosing cholangitis in Italy: A population-based study 204
FRI-006-Soluble CD163 and mannose receptor as markers of liver disease severity and long term prognosis in patients with primary biliary cholangitis 198
Mapping the human genetic architecture of COVID-19 198
Precision medicine in primary biliary cholangitis 197
Risk stratification in primary sclerosing cholangitis 195
Accuracy of Liver Stiffness Measurement in assessing liver fibrosis in naïve patients with Primary Biliary Cholangitis 193
Antitumor Activity of a Novel Fibroblast Growth Factor Receptor Inhibitor for Intrahepatic Cholangiocarcinoma 186
Additive beneficial effects of Fibrates combined with Obeticholic acid in the treatment of patients with Primary Biliary Cholangitis and inadequate response to second-line therapy: data from the Italian PBC Study Group 184
THU-010-Shedding light on the X chromosome contribution to the genetic architecture of primary biliary cholangitis 180
Accuracy of Transient Elastography in assessing fibrosis at diagnosis in naïve patients with Primary Biliary Cholangitis: a dual cut-off approach 179
FRI-011-Ductular reaction, intermediate hepatocites and fibrosis extension correlate with prediction of treatment failure to ursodeoxycholic acid in primary biliary cholangitis 173
Support of precision medicine through risk-stratification in autoimmune liver diseases - histology, scoring systems, and non-invasive markers 172
Multiple therapeutic targets in rare cholestatic liver diseases: Time to redefine treatment strategies 172
New Therapeutic Targets in Autoimmune Cholangiopathies 171
A National Hospital‐Based Study of Hospitalized Patients With Primary Biliary Cholangitis 170
Novel insights in primary biliary cholangitis (PBC) epidemiology using administrative records 168
Measurement of Gamma Glutamyl Transferase to Determine Risk of Liver Transplantation or Death in Patients With Primary Biliary Cholangitis 168
An international genome-wide meta-analysis of primary biliary cholangitis: Novel risk loci and candidate drugs 168
A quantitative MRCP-derived score for medium-term outcome prediction in primary sclerosing cholangitis 167
Coronavirus Disease 2019 (COVID-19) in autoimmune hepatitis: a lesson from immunosuppressed patients 159
Primary biliary cholangitis: a multifaceted pathogenesis with potential therapeutic targets 156
Immune-mediated drug-induced liver injury: Immunogenetics and experimental models 154
Detailed stratified GWAS analysis for severe COVID-19 in four European populations 152
Machine learning in primary biliary cholangitis: A novel approach for risk stratification 146
Outcome of COVID-19 in Patients With Autoimmune Hepatitis: An International Multicenter Study 139
Association Between Black Race and Presentation and Liver-Related Outcomes of Patients With Autoimmune Hepatitis 137
Soluble CD163 and mannose receptor as markers of liver disease severity and prognosis in patients with primary biliary cholangitis 135
X Chromosome Contribution to the Genetic Architecture of Primary Biliary Cholangitis 133
The immunobiology of female predominance in primary biliary cholangitis 130
Predictors of serious adverse events and non-response in cirrhotic patients with primary biliary cholangitis treated with obeticholic acid 118
The application of artificial intelligence in hepatology: A systematic review 117
Gender differences in liver disease and the drug-dose gender gap 116
DISSECTING THE GENETIC ARCHITECTURE OF AUTOIMMUNITY: A SPOTLIGHT ON PRIMARY BILIARY CHOLANGITIS 115
Cost of illness of Primary Biliary Cholangitis - a population-based study 113
Normalization of serum immunoglobulin G levels is associated with improved transplant-free survival in patients with autoimmune hepatitis 108
The prognosis following bacterascites is as poor as spontaneous bacterial peritonitis 102
The role of ethnicity in autoimmune hepatitis 99
Primary sclerosing cholangitis: Burden of disease and mortality using data from the national rare diseases registry in Italy 99
Case Report: Hypomorphic Function and Somatic Reversion in DOCK8 Deficiency in One Patient With Two Novel Variants and Sclerosing Cholangitis 94
Artificial Intelligence and liver: Opportunities and barriers 93
Geographical region and clinical outcomes of patients with primary biliary cholangitis from Western Europe 90
Long-term impact of preventive UDCA therapy after transplantation for primary biliary cholangitis 89
Real-world experience with obeticholic acid in patients with primary biliary cholangitis 89
Identifying Racial Disparities in Primary Biliary Cholangitis Patients: A Step Toward Achieving Equitable Outcomes Among All 88
Elevated baseline igg is a risk factor for on-treatment flares of autoimmune hepatitis in patients in biochemical remission 84
Role of ductular reaction and ductular–canalicular junctions in identifying severe primary biliary cholangitis 83
Improving predictive accuracy in primary biliary cholangitis: A new genetic risk score 81
Corrigendum to ‘An international genome-wide meta-analysis of primary biliary cholangitis: Novel risk loci and candidate drugs’ [J Hepatol 2021;75(3):572–581] (Journal of Hepatology (2021) 75(3) (572–581), (S0168827821003342), (10.1016/j.jhep.2021.04.055)) 81
Artificial intelligence for precision medicine in autoimmune liver disease 80
Systematic review of response criteria and endpoints in autoimmune hepatitis by the International Autoimmune Hepatitis Group 78
Effects of immunosuppressive drugs on COVID-19 severity in patients with autoimmune hepatitis 74
A quantitative MRCP-derived score for medium-term outcome prediction in primary sclerosing cholangitis 67
The Role of Macrophages in Liver Fibrosis: New Therapeutic Opportunities 67
Effects of Tumor Necrosis Factor Antagonists in Patients With Primary Sclerosing Cholangitis 64
LLM-PBC: Logic Learning Machine-Based Explainable Rules Accurately Stratify the Genetic Risk of Primary Biliary Cholangitis 62
Corrigendum to: “An international genome-wide meta-analysis of primary biliary cholangitis: Novel risk loci and candidate drugs” [J Hepatol 75 (2021) 572-581, (S0168827821003342), (10.1016/j.jhep.2021.04.055)] 60
Editorial: liver transplantation for primary biliary cholangitis–the need for timely and more effective treatments 60
SARS-CoV-2 vaccination and risk of severe COVID-19 outcomes in patients with autoimmune hepatitis 59
X marks the spot in autoimmunity 57
The Role of Epigenetics in Primary Biliary Cholangitis 55
GWAS and autoimmunity: What have we learned and what next 52
New insights on the role of human leukocyte antigen complex in primary biliary cholangitis 51
Open challenges in the management of autoimmune hepatitis 49
Genetics of Primary Biliary Cholangitis 49
Bacterascites confers poor patient prognosis beyond MELD prediction 46
Anti-gp210 and other anti-nuclear pore complex autoantibodies in primary biliary cholangitis: What we know and what we should know 46
The genetic architecture of primary biliary cholangitis 43
MEDTEC students against coronavirus: Investigating the role of hemostatic genes in the predisposition to COVID-19 severity 43
Primary Sclerosing Cholangitis 38
Serum gamma-glutamyltransferase is a prognostic biomarker in primary biliary cholangitis and improves risk stratification based on alkaline phosphatase 31
Soluble CD163 and mannose receptor as markers of liver disease severity and long term prognosis in patients with primary biliary cholangitis 30
ANTITUMOR ACTIVITY OF A NOVEL FGFR INHIBITOR IN INTRAHEPATIC CHOLANGIOCARCINOMA 30
Pre-treatment risk stratification in primary biliary cholangitis: A predictive model to guide first-line combination therapy 30
Stratified analyses refine association between TLR7 rare variants and severe COVID-19 29
Genetics of Autoimmune Liver Diseases 29
Cluster analysis reveals the prognostic role of serum albumin within the normal range in patients with primary biliary cholangitis 29
EFFICACY OF OBETICHOLIC ACID IN PRIMARY BILIARY CHOLANGITIS-AUTOIMMUNE HEPATITIS OVERLAP PATIENTS WITH PERSISTENTLY ELEVATED TRANSAMINASES DESPITE IMMUNOSUPPRESSION 28
NON ADHERENCE TO AASLD - EASL GUIDELINES FOR THE MANAGEMENT OF HEPATOCELLULAR CARCINOMA DOES NOT TRANSLATE INTO WORSE OUTCOMES 28
A NOVEL MACHINE-LEARNING, COMMON VARIANTS-BASED APPROACH TO PREDICT PRIMARY BILIARY CHOLANGITIS 27
Gamma-Glutamyl Transferase in Patients With Primary Biliary Cholangitis 25
Serum gamma-glutamyltransferase is a prognostic biomarker in primary biliary cholangitis and improves risk stratification based on the alkaline phosphatase 25
Association between black race and presentation and liver-related outcomes of patients with autoimmune hepatitis 25
Incomplete normalization of transaminases at 18 months is the most important predictor for failure of biochemical response in autoimmune hepatitis 24
Ductular reaction, intermediate hepatocytes and fibrosis extension correlate with prediction of treatment failure to ursodeoxycholic acid in primary biliary cholangitis 22
Shedding light on the X chromosome contribution to the genetic architecture of primary biliary cholangitis 21
The prognosis following bacterascites is as poor as spontaneous bacterial peritonitis 18
Established cirrhosis at the time of diagnosis predicts adverse outcome in autoimmune hepatitis: A retrospective cohort study 18
Black Ethnicity Affects the Clinical Presentation and Outcome in Autoimmune Hepatitis 17
EVALUATION OF PROGNOSTIC FACTORS OF OVERALL SURVIVAL AND PROGRESSION-FREE SURVIVAL IN PATIENTS WITH HEPATOCELLULAR CARCINOMA (HCC) 17
The impact of geographical region on outcomes of patients with primary biliary cholangitis from western Europe 17
Primary Biliary Cholangitis 16
Clustering Reveals the Prognostic Role of Serum Albumin Values Within the Normal Range in Patients with Primary Biliary Cholangitis 16
Cost of Illness of Primary Biliary Cholangitis in Lombardia 14
Totale 9.854
Salva come PNG Salva come JPEG
Categoria #
all - tutte 45.606
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 45.606
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2019/2020167 0 0 0 0 0 0 0 0 0 92 52 23
2020/20211.525 34 29 276 66 122 205 170 223 102 85 119 94
2021/20221.051 107 104 160 108 79 61 43 69 48 25 85 162
2022/20231.850 172 440 148 141 236 245 86 90 112 64 70 46
2023/20241.644 49 59 75 161 187 328 207 37 76 172 40 253
2024/20252.617 254 400 218 187 325 197 247 209 426 154 0 0
Totale 9.854